FSHCX vs. FBTTX

Last updated Jun 4, 2026

FSHCX (Fidelity Select Health Care Services Portfolio) and FBTTX (Fidelity Advisor Biotechnology Fund Class M) are both Health & Biotech Equities funds from Fidelity. Over the past 10 years, FSHCX returned 8.22%/yr vs 10.20%/yr for FBTTX. A 0.53 correlation means they provide meaningful diversification when combined. FSHCX charges 0.71%/yr vs 1.28%/yr for FBTTX.

Performance

FSHCX vs. FBTTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Select Health Care Services Portfolio (FSHCX) and Fidelity Advisor Biotechnology Fund Class M (FBTTX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, FSHCX achieves a 1.77% return, which is significantly higher than FBTTX's -0.94% return. Over the past 10 years, FSHCX has underperformed FBTTX with an annualized return of 8.22%, while FBTTX has yielded a comparatively higher 10.20% annualized return.

FSHCX

• 1D: -0.91%
• 1M: -0.80%
• YTD: 1.77%
• 6M: 2.10%
• 1Y: 5.67%
• 3Y*: -1.01%
• 5Y*: -0.25%
• 10Y*: 8.22%

FBTTX

• 1D: -3.06%
• 1M: -5.59%
• YTD: -0.94%
• 6M: -4.29%
• 1Y: 43.95%
• 3Y*: 16.69%
• 5Y*: 8.98%
• 10Y*: 10.20%

*Multi-year figures are annualized to reflect compound growth (CAGR)

FSHCX vs. FBTTX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
FSHCX Fidelity Select Health Care Services Portfolio	1.77%	3.85%	-13.21%	1.52%	0.86%	20.22%	18.58%	19.91%	10.17%	24.46%
FBTTX Fidelity Advisor Biotechnology Fund Class M	-0.94%	39.21%	5.08%	10.43%	-8.22%	-3.35%	31.82%	25.39%	-4.19%	25.37%

Correlation

The correlation between FSHCX and FBTTX is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.25
Correlation (3Y) Calculated over the trailing 3-year period	0.30
Correlation (5Y) Calculated over the trailing 5-year period	0.40
Correlation (10Y) Calculated over the trailing 10-year period	0.47
Correlation (All Time) Calculated using the full available price history since Dec 28, 2000	0.53

Over the past year, the correlation between FSHCX and FBTTX has dropped to 0.25 - well below their long-term average of 0.53, suggesting their price drivers have been diverging.

Return for Risk

FSHCX vs. FBTTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FSHCX

FSHCX Risk / Return Rank: 4
FSHCX Sharpe Ratio Rank: 4
FSHCX Sortino Ratio Rank: 4
FSHCX Omega Ratio Rank: 4
FSHCX Calmar Ratio Rank: 4
FSHCX Martin Ratio Rank: 4

FBTTX

FBTTX Risk / Return Rank: 62
FBTTX Sharpe Ratio Rank: 50
FBTTX Sortino Ratio Rank: 46
FBTTX Omega Ratio Rank: 40
FBTTX Calmar Ratio Rank: 92
FBTTX Martin Ratio Rank: 80

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FSHCX vs. FBTTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Health Care Services Portfolio (FSHCX) and Fidelity Advisor Biotechnology Fund Class M (FBTTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	FSHCX	FBTTX	Difference
Sharpe ratio: Return per unit of total volatility	0.26	2.08	-1.82
Sortino ratio: Return per unit of downside risk	0.47	2.85	-2.38
Omega ratio: Gain probability vs. loss probability	1.07	1.34	-0.27
Calmar ratio: Return relative to maximum drawdown	0.31	5.12	-4.81
Martin ratio: Return relative to average drawdown	0.79	14.99	-14.20
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

FSHCX vs. FBTTX - Sharpe Ratio Comparison

The current FSHCX Sharpe Ratio is 0.26, which is lower than the FBTTX Sharpe Ratio of 2.08. The chart below compares the historical Sharpe Ratios of FSHCX and FBTTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	FSHCX	FBTTX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.26	2.08	-1.82
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.01	0.38	-0.40
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.38	0.42	-0.04
Sharpe Ratio (All Time) Calculated using the full available price history	0.54	0.29	+0.24

Drawdowns

FSHCX vs. FBTTX - Drawdown Comparison

The maximum FSHCX drawdown since its inception was -57.81%, smaller than the maximum FBTTX drawdown of -63.75%. Use the drawdown chart below to compare losses from any high point for FSHCX and FBTTX.

Drawdown Indicators

	FSHCX	FBTTX	Difference
Max Drawdown Largest peak-to-trough decline	-57.81%	-63.75%	+5.94%
Max Drawdown (1Y) Largest decline over 1 year	-17.15%	-8.94%	-8.21%
Max Drawdown (3Y) Largest decline over 3 years	-29.52%	-32.91%	+3.39%
Max Drawdown (5Y) Largest decline over 5 years	-29.52%	-36.64%	+7.12%
Max Drawdown (10Y) Largest decline over 10 years	-35.48%	-39.04%	+3.56%
Current Drawdown Current decline from peak	-12.91%	-8.94%	-3.97%
Average Drawdown Average peak-to-trough decline	-11.37%	-21.83%	+10.46%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.75%	3.05%	+3.70%

Volatility

FSHCX vs. FBTTX - Volatility Comparison

The current volatility for Fidelity Select Health Care Services Portfolio (FSHCX) is 4.66%, while Fidelity Advisor Biotechnology Fund Class M (FBTTX) has a volatility of 7.09%. This indicates that FSHCX experiences smaller price fluctuations and is considered to be less risky than FBTTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FSHCX	FBTTX	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.66%	7.09%	-2.43%
Volatility (6M) Calculated over the trailing 6-month period	15.20%	16.71%	-1.51%
Volatility (1Y) Calculated over the trailing 1-year period	20.34%	22.10%	-1.76%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	19.17%	23.46%	-4.29%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	21.47%	24.41%	-2.94%

FSHCX vs. FBTTX - Expense Ratio Comparison

FSHCX has a 0.71% expense ratio, which is lower than FBTTX's 1.28% expense ratio.

Dividends

FSHCX vs. FBTTX - Dividend Comparison

FSHCX's dividend yield for the trailing twelve months is around 0.74%, less than FBTTX's 1.55% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FBTTX Fidelity Advisor Biotechnology Fund Class M	1.55%	1.53%	6.41%	0.93%	0.00%	21.60%	8.79%	7.10%	2.64%	0.00%	0.00%	5.42%
FSHCX Fidelity Select Health Care Services Portfolio	0.74%	0.75%	16.63%	0.57%	5.32%	7.09%	0.76%	0.27%	12.92%	13.41%	4.62%	4.06%

Frequently Asked Questions

Can I hold both FSHCX and FBTTX in my portfolio?

FSHCX and FBTTX have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, FSHCX or FBTTX?

FBTTX has higher volatility (7.09%) compared to FSHCX (4.66%). In terms of maximum drawdown, FSHCX dropped -57.81% vs FBTTX's -63.75%.

Which has better risk-adjusted returns?

FBTTX currently has the higher Sharpe Ratio (2.08 vs 0.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.